Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia
1 other identifier
interventional
120
1 country
1
Brief Summary
It is already known that fascia iliaca compartment block and intrathecal nalbuphine are very effective ways in postoperative pain control in patients having hip surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Feb 2025
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
February 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedNovember 19, 2025
November 1, 2025
1.1 years
February 5, 2025
November 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time to first rescue analgesia (minutes).
Time to first rescue analgesia (minutes).
in the first 24 hours after surgery
Study Arms (3)
US-guided fascia iliaca compartment block (FICB) and spinal anesthesia
ACTIVE COMPARATORIntrathecal nalbuphine and spinal anesthesia
ACTIVE COMPARATORSpinal anesthesia
OTHERInterventions
US-guided fascia iliaca compartment block (FICB) and spinal anesthesia
intrathecal nalbuphine and spinal anesthesia
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) score (ASA I- ASA II).
- Age ≥ 21years.
- Body mass index \< 35 kg/m2
You may not qualify if:
- Patient's refusal.
- Known coagulopathy.
- Known peripheral neuropathy or neurological deficits.
- Known allergy to study drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain-Shams University Hospitals
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesia and Intensive Care,Faculty of Medicine, Ain- shams University, Cairo, Egypt.
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 10, 2025
Study Start
February 18, 2025
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11